Education
About Us
Working with TipRanks
Follow Us
Vaso Corp. (VASO)
OTHER OTC:VASO
VASO Stock Chart & Stats
$0.17
>-$0.01(-2.42%)
At close: 4:00 PM EST
$0.17
>-$0.01(-2.42%)
Day’s Range― - ―
52-Week Range$0.11 - $0.21
Previous CloseN/A
Volume57.70K
Average Volume (3M)98.46K
Market Cap
$31.24M
Enterprise Value-$4.52M
Total Cash (Recent Filing)$34.86M
Total Debt (Recent Filing)$2.81M
Price to Earnings (P/E)12.0
Beta0.30
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding175,953,030
10 Day Avg. Volume66,687
30 Day Avg. Volume98,461
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.76
Price to Sales (P/S)0.24
P/FCF Ratio11.50
Enterprise Value/Market Cap-0.14
Enterprise Value/Revenue-0.05
Enterprise Value/Gross Profit-0.08
Enterprise Value/Ebitda-1.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet / Low LeverageVery low leverage and a robust equity base reduce financial risk and increase resilience to downturns. Improved ROE shows management can generate returns from capital. This durability supports long-term investments in product development and protects against liquidity shocks.
Improving Free Cash Flow GenerationSustained FCF growth and FCF exceeding reported earnings indicate strong cash conversion and internal funding capacity. Durable cash generation funds R&D, device production, and subscriptions expansion without heavy external financing, improving strategic optionality.
Strategic Divestiture Of Non-core UnitSelling a small, non-core reseller unit sharpens strategic focus on telehealth, devices, and analytics. The proceeds and management bandwidth can be redeployed into higher-margin core offerings, improving long-term operational focus and capital efficiency.
Bears Say
Negative Net Profit MarginA persistent negative net margin undermines sustainable profitability even if gross margins are healthy. Over time this can deplete reserves, limit reinvestment capacity, and force difficult trade-offs between growth and cost control unless operating profits are restored.
Declining EBIT / EBITDA MarginsFalling operating margins point to structural cost or efficiency weaknesses in scaling the business. If not addressed, these inefficiencies will compress operating cash flows, restrict margin expansion from subscription scale, and hamper competitiveness long term.
Modest Revenue Growth RateLow single-digit top-line growth limits scale benefits for a subscription and device business. Structural growth below peer expectations increases reliance on margin improvements or M&A to create shareholder value and raises execution risk over the next several quarters.
Vaso News
VASO FAQ
What was Vaso Corp.’s price range in the past 12 months?
Vaso Corp. lowest stock price was $0.10 and its highest was $0.20 in the past 12 months.
What is Vaso Corp.’s market cap?
Vaso Corp.’s market cap is $31.24M.
When is Vaso Corp.’s upcoming earnings report date?
Vaso Corp.’s upcoming earnings report date is Apr 01, 2026 which is in 27 days.
How were Vaso Corp.’s earnings last quarter?
Vaso Corp. released its earnings results on Nov 14, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of N/A by $0.01.
Is Vaso Corp. overvalued?
According to Wall Street analysts Vaso Corp.’s price is currently Overvalued.
Does Vaso Corp. pay dividends?
Vaso Corp. does not currently pay dividends.
What is Vaso Corp.’s EPS estimate?
Vaso Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaso Corp. have?
Vaso Corp. has 175,953,030 shares outstanding.
What happened to Vaso Corp.’s price movement after its last earnings report?
Vaso Corp. reported an EPS of $0.01 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 9.091%.
Which hedge fund is a major shareholder of Vaso Corp.?
Currently, no hedge funds are holding shares in VASO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vaso Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.12%
12-Months-Change
Fundamentals
Return on Equity
-1.14%
Trailing 12-Months
Asset Growth
14.60%
Trailing 12-Months
Company Description
Vaso Corp.
Vaso (VASO) is a technology-driven company focused on providing innovative solutions in the healthcare and medical sectors. The company specializes in developing advanced telehealth platforms and medical products that enhance patient care and streamline healthcare operations. Vaso's core offerings include telemedicine software, remote monitoring devices, and health data analytics services that cater to healthcare providers, patients, and medical institutions.
Technical Analysis
Healthcare Triangle
―
HeartBeam
―
VSee Health
―
BullFrog AI Holdings, Inc.
―
Mangoceuticals, Inc.
―